MBL2 gene variants and susceptibility to meningitis in Egyptian patients

Mona F Sokkar1, Rehab M Mosaad1, Mahmoud Khalil2

  • 1Molecular Genetics and Enzymology Department, Human Genetics and Genome Research Institute (HGGR), National Research Centre (NRC), Cairo, Egypt.

Gene
|April 30, 2023
PubMed
Abstract

Insights

Genetic variants in the Mannose Binding Lectin 2 (MBL2) gene, specifically promoter (c.-290C>G) and UTR (c.-66C>T) variants, are associated with increased meningitis susceptibility in Egyptian patients. The MBL2 c.170G>A variant may offer protection against severe outcomes.

Area of Science:

  • Genetics
  • Immunology
  • Molecular Biology

Background:

  • Meningitis is a life-threatening inflammation of the membranes surrounding the brain and spinal cord.
  • Mannose binding lectin (MBL), encoded by the MBL2 gene, plays a crucial role in innate immunity by activating the complement system against infections.

Purpose of the Study:

  • To investigate the association between MBL2 gene promoter and exon 1 variants and meningitis susceptibility in Egyptian patients.
  • To explore the potential role of these MBL2 variants in disease susceptibility and clinical outcomes.

Main Methods:

  • A case-control study involving 53 meningitis patients and 50 age- and sex-matched healthy controls.
  • Genotyping of MBL2 gene variants was performed using Sanger sequencing.

Main Results:

  • The promoter variant (c.-290C>G) and the 5'UTR variant (c.-66C>T) of the MBL2 gene showed a significantly higher prevalence in meningitis patients compared to controls (p=0.0001 and p=0.033, respectively).
  • No significant difference was observed in the incidence of four individual exon 1 variants (c.161G>A, c.170G>A, c.154C>T, c.132C>T) between cases and controls.
  • The MBL2 c.170G>A variant (C allele) was associated with a favorable clinical outcome in meningitis patients (p=0.025).

Conclusions:

  • MBL2 promoter (c.-290C>G) and UTR (c.-66C>T) variants may represent potential risk factors for meningitis susceptibility in the Egyptian population.
  • The MBL2 c.170G>A variant (C allele and CC genotype) may play a protective role, potentially influencing disease severity.
  • Investigated MBL2 variants c.132C>T, c.161G>A, and c.154C>T were not associated with meningitis susceptibility or severity.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...